M4MM
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
The Supreme Court Declines to Resolve Federal Cannabis Prohibition—And the Silence Speaks Volumes
WASHINGTON, D.C. – In its December Orders List, the U.S. Supreme Court declined to hear a case that many hoped would finally force a reckoning between federal Cannabis prohibition and state-legal markets. By declining review, ...
Ascend Wellness Partners with Cannabis Advocate for New Dispensary in New Jersey
NEW YORK – Ascend Wellness Holdings Inc. disclosed a partnership with Mister Jones LLC and industry advocate Lerone Jones to launch a retail dispensary in Little Falls, NJ. The arrangement, one of the initial deals ...
Grown Rogue Claims Ground in Minnesota
MINNEAPOLIS – Grown Rogue International Inc., a Сannabis MSO focused on premium flower, has signed a long-term lease for a 109,000-square-foot facility in Fridley, just north of Minneapolis, positioning the company to produce for the ...
New Mexico Speeds Up Psilocybin Therapy Access
SANTA FE – State health leaders in New Mexico outlined plans this week to open a regulated psilocybin therapy program by the close of 2026, advancing the timeline a full year from the original statutory ...
Stiiizy Expands California Retail Network Buying 12 Gold Flora Outlets
LOS ANGELES – Stiiizy, the dominant player in California's Cannabis retail, has taken control of 12 former Gold Flora dispensaries in a $25 million court-approved transaction, marking a key step in the state's ongoing industry ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
The Supreme Court Declines to Resolve Federal Cannabis Prohibition—And the Silence Speaks Volumes
WASHINGTON, D.C. – In its December Orders List, the U.S. Supreme Court declined to hear a case that many hoped would finally force a reckoning between federal Cannabis prohibition and state-legal markets. By declining review, ...
Trulieve Redeems $368M in Notes, Signaling Debt Reduction Push
TALLAHASSEE – Trulieve Cannabis Corp. has announced its decision to redeem its entire $368 million portfolio of 8.0% senior secured notes, due in 2026. The company issued the redemption notice, setting an early payoff date ...
Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about ...
New Mexico Cannabis Market Edges Toward $2B in Total Sales
ALBUQUERQUE – New Mexico's Cannabis industry has recorded $1.9 billion in combined medical and adult-use sales since recreational legalization took effect in April 2022, according to the latest figures from the state’s Regulation and Licensing ...
Fairfax Bank Retreats from Servicing Cannabis Businesses
FAIRFAX – MainStreet Bancshares Inc., a community lender with $2.2 billion in assets, has shelved its Cannabis banking program just eight months after unveiling it as a growth driver. The decision, disclosed by CEO Jeff ...
Stiiizy Halts Sales at Catalyst Outlets as Leadership Clash Deepens
LOS ANGELES – Stiiizy, California's dominant Cannabis brand with a footprint in Arizona, Michigan, and Nevada, has stopped supplying its products to Catalyst Cannabis Co. stores, marking a sharp break in what was once a ...
Arizona Funds Nation’s First Whole-Mushroom Psilocybin Trial Targeting PTSD in Veterans & First Responders
PHOENIX – State officials in Arizona have authorized and financed what amounts to the country's initial controlled study of whole psilocybin mushrooms as a treatment for post-traumatic stress disorder (PTSD) among police officers, firefighters, and ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, posted its highest quarterly revenue on record for the period ended September 30, with sales reaching A$14.1 million, a 210% jump from the ...
Kansas Poll Shows Broad Support for Cannabis Reform
TOPEKA – A recent survey of Kansas residents highlights growing public enthusiasm for Cannabis policy changes, with nearly seven in ten adults endorsing medical use and close to six in ten favoring recreational access. A ...
Cybin Raises $175M in Direct Offering, Reinforcing Psychedelic Pipeline
TORONTO – Cybin Inc., a clinical-stage biopharmaceutical company focused on psychedelic-based treatments for mental health disorders, disclosed a $175 million registered direct offering, drawing commitments from a roster of established biotech investors. The deal, priced ...
MariMed Steps Away from Missouri Operations
NORWOOD – In a sharp turn from expansion plans, MariMed Inc. announced it is shutting down its Missouri operations, ending a yearlong effort to build a foothold in the state's burgeoning recreational market and opting ...
Lebanon Legalizes Cannabis, Forms Oversight Body, Targeting $1B in Annual Revenue
BEIRUT – In a significant step forward in leveraging its Cannabis sector for economic relief, the Lebanese government established a dedicated committee to regulate the cultivation and sales of Cannabis under a long-dormant 2020 law. ...
Verano Shareholders Approve Corporate Home Relocation to Nevada
CHICAGO – Verano Holdings Corp. secured strong backing from investors to move its parent company's legal base from British Columbia, Canada, to Nevada. The approval came during a special shareholder meeting, clearing a key hurdle ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Executives and operators in the Cannabis and psychedelics sectors wrapped up another fortnight with a mix of regulatory headwinds, financial maneuvers, and market validations that underscore the sector's resilience. From bipartisan efforts ...
